e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
COPD - pathogenesis I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
HsCRP is associated with COPD and a faster decline in FEV
1
- a multicentre epidemiological study
T. Gislason, I. S. Olafsdottir, B. Thjodleifsson, I. Olafsson, D. Gislason, R. Jogin, C. Janson (Reykjavik, Iceland; Tartu, Estonia; Uppsala, Sweden)
Source:
Annual Congress 2005 - COPD - pathogenesis I
Session:
COPD - pathogenesis I
Session type:
Thematic Poster Session
Number:
438
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Gislason, I. S. Olafsdottir, B. Thjodleifsson, I. Olafsson, D. Gislason, R. Jogin, C. Janson (Reykjavik, Iceland; Tartu, Estonia; Uppsala, Sweden). HsCRP is associated with COPD and a faster decline in FEV
1
- a multicentre epidemiological study. Eur Respir J 2005; 26: Suppl. 49, 438
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
A prospective study of systemic inflammation and FEV
1
decline
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005
Predictors of accelerated decline in FEV1 in a prospective new-onset asthma cohort
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
A multicentre cohort study on the association between common markers of asthma and the incidence of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 295s
Year: 2006
An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019
Quality of forced spirometry in a worldwide multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010
Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
COPD and its comorbidities – prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 79s
Year: 2007
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Changes in FEV1 over 8 years in COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma - A long-term prospective cohort study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021
The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001
Colonisation in stable patients with COPD: results of an Italian epidemiological study (PRIME study)
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept